We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 3,350

FDA revises informed consent regulations to incorporate clinical trial registration requirements
  • Latham & Watkins LLP
  • USA
  • January 7 2011

On Tuesday, January 4, 2011, the U.S. Food and Drug Administration (FDA) issued a Final Rule amending the current informed consent regulations pursuant to the requirements of the Food and Drug Administration Amendments Act of 20072 (FDAAA


IRS to require taxpayers to “self-identify” potential tax issues
  • Latham & Watkins LLP
  • USA
  • January 20 2010

The IRS announced a plan yesterday (January 26, 2010) designed to give its auditors a road map for identifying uncertain tax positions reported on the tax returns of certain business taxpayers


Non EU-based companies using French data processors for payroll, customers and prospects data exempted from prior notification
  • Latham & Watkins LLP
  • France
  • April 4 2011

In a decision published on February 16, 2011 (Deliberation No. 2011-023), the French data protection authority (CNIL) exempted non EU-based companies from any prior notification obligation with regard to their payroll, customer and prospects data processed in France


QFC funds update: the QFCRA’s new regime for collective investment schemes
  • Latham & Watkins LLP
  • Qatar
  • January 27 2011

The new year has witnessed the introduction of significant revisions to the regulatory regime for collective investment schemes operating in or from the Qatar Financial Centre (the QFC


FDA announces actions designed to improve the 510(k) premarket clearance process
  • Latham & Watkins LLP
  • USA
  • January 27 2011

On Wednesday, January 19, 2011, the FDA released a plan to improve the current 510(k) program by announcing 25 action items "it intends to implement during 2011 to improve the most common path to market for medical devices."


UK Bribery Act 2010: UK authorities publish implementation date and guidance about procedures and prosecutions
  • Latham & Watkins LLP
  • United Kingdom
  • March 30 2011

The UK authorities have today published long-awaited guidance materials on the UK Bribery Act 2010 guidance about procedures for preventing bribery by the UK Ministry of Justice (MoJ), and prosecution guidance by the UK Serious Fraud Office (SFO


Ninth Circuit’s "federal defendant" intervention rule in NEPA cases finally meets its end: Wilderness Society v. United States Forest Service
  • Latham & Watkins LLP
  • USA
  • February 22 2011

In a significant decision issued in mid-January 2011, the U.S. Court of Appeals for the Ninth Circuit (en banc) abandoned its categorical rule that a party may not intervene of right in the merits of a National Environmental Policy Act (NEPA) case


“Flip” flap II: uncertainty in derivatives markets caused by the Lehman bankruptcy court’s decision will continue
  • Latham & Watkins LLP
  • USA
  • February 17 2011

On December 15, 2010, Judge James Peck of the US Bankruptcy Court for the Southern District of New York (the Bankruptcy Court) approved Lehman Brothers Special Financing Inc.’s (LBSF) motion (the Motion) for approval of a settlement among LBSF, BNY Corporate Trustee Services Limited (BNY), Perpetual Trustee Company Limited (Perpetual) and others relating to certain note issuance and swap transactions with Saphir Finance Public Limited Company (Saphir) under a program known as the Dante Program


An end to the rule of thumb: Uniloc USA, Inc. v. Microsoft Corp
  • Latham & Watkins LLP
  • USA
  • March 1 2011

Before the Federal Circuit’s recent decision in Uniloc USA, Inc. v. Microsoft Corp., patentees often used the so-called 25 percent rule to approximate a reasonable royalty ratei.e., the royalty rate that an accused infringer would have paid to the patentee during a hypothetical negotiation at the time infringement began


CFTC Form 4040S reporting requirements
  • Latham & Watkins LLP
  • USA
  • June 26 2014

The U.S. Commodity Futures Trading Commission (CFTC) has seemingly increased the number of Form 4040S requests it has sent to market participants in